Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?
about
Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?
description
im Mai 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 09 May 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2018
@uk
name
Inter-individual variation in ...... P3A5 in Nigerian CML patients?
@en
Inter-individual variation in ...... P3A5 in Nigerian CML patients?
@nl
type
label
Inter-individual variation in ...... P3A5 in Nigerian CML patients?
@en
Inter-individual variation in ...... P3A5 in Nigerian CML patients?
@nl
prefLabel
Inter-individual variation in ...... P3A5 in Nigerian CML patients?
@en
Inter-individual variation in ...... P3A5 in Nigerian CML patients?
@nl
P2093
P50
P1433
P1476
Inter-individual variation in ...... P3A5 in Nigerian CML patients?
@en
P2093
Muheez A Durosinmi
Rahman A Bolarinwa
Tiwalade A Olugbade
P304
P356
10.1080/10428194.2018.1466291
P577
2018-05-09T00:00:00Z